Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. Keeping that in mind, here are three profitable companies that don’t make the cut and some better opportunities instead.
Covista (CVSA)
Trailing 12-Month GAAP Operating Margin: 19.3%
Formerly known as DeVry Education Group, Covista (NYSE: CVSA) is a global provider of workforce solutions and educational services.
Why Are We Out on CVSA?
- Sales trends were unexciting over the last five years as its 13.9% annual growth was below the typical consumer discretionary company
- Projected 3.8 percentage point decline in its free cash flow margin next year reflects the company’s plans to increase its investments to defend its market position
- Below-average returns on capital indicate management struggled to find compelling investment opportunities
Covista is trading at $116.40 per share, or 14.3x forward P/E. If you’re considering CVSA for your portfolio, see our FREE research report to learn more.
Enpro (NPO)
Trailing 12-Month GAAP Operating Margin: 15.1%
Holding a Guinness World Record for creating the world's largest gasket, Enpro (NYSE: NPO) designs, manufactures, and sells products used for machinery in various industries.
Why Is NPO Not Exciting?
- Muted 1.3% annual revenue growth over the last five years shows its demand lagged behind its industrials peers
- ROIC of 6.9% reflects management’s challenges in identifying attractive investment opportunities
At $249.13 per share, Enpro trades at 28.8x forward P/E. Read our free research report to see why you should think twice about including NPO in your portfolio.
U.S. Physical Therapy (USPH)
Trailing 12-Month GAAP Operating Margin: 11.1%
With a nationwide footprint spanning 671 clinics across 42 states, U.S. Physical Therapy (NYSE: USPH) operates a network of outpatient physical therapy clinics and provides industrial injury prevention services to employers across the United States.
Why Are We Hesitant About USPH?
- Modest revenue base of $781 million gives it less fixed cost leverage and fewer distribution channels than larger companies
- Incremental sales over the last five years were less profitable as its 1.9% annual earnings per share growth lagged its revenue gains
- 6 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position
U.S. Physical Therapy’s stock price of $74.39 implies a valuation ratio of 26x forward P/E. To fully understand why you should be careful with USPH, check out our full research report (it’s free).
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
